The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.

Saved in:
Bibliographic Details
Title: The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals.
Authors: Berner AM; Barts Cancer Institute, Queen Mary University of London, United Kingdom; Gender Identity Clinic London, Tavistock and Portman NHS Trust, United Kingdom. Electronic address: alison.berner@nhs.net., Atkinson SE; St Bartholomew's Hospital, Barts Health NHS Trust, United Kingdom.
Source: Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2024 Sep; Vol. 38 (5), pp. 101909. Date of Electronic Publication: 2024 Jun 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120682 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1594 (Electronic) Linking ISSN: 1521690X NLM ISO Abbreviation: Best Pract Res Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1594
DOI:10.1016/j.beem.2024.101909